Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 1,110

Document Document Title
WO/2014/180984A1
The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer hematological mal...  
WO/2014/157216A1
The present invention addresses the problem of providing a photoelectric conversion material well-suited for continuous evaporation, a photoelectric transducer in which the photoelectric conversion material is used, a method for using th...  
WO/2014/156184A1
[Problem] To provide: an organic photoelectric conversion element which has good response speed, carrier transport properties (sensitivity) and heat resistance; and an imaging element which is provided with this organic photoelectric con...  
WO/2014/157238A1
The present invention addresses the problem of providing a photoelectric conversion material that excels in heat resistance and vapor-deposition stability, a photoelectric conversion element using the photoelectric conversion material, a...  
WO/2014/146752A1
The present application relates to a compound of a formula (I) which comprises a benzene group that is substituted with a group selected from carbazole derivatives and bridged amines and with an electron attracting group, wherein the two...  
WO/2014/123485A1
A method for the purification of a desired protein from a protein preparation includes conditioning the protein preparation by treatment with soluble organic multivalent ions, immobilized organic multivalent ions, or both, optionally in ...  
WO/2014/104315A1
This electroluminescent element is characterized by comprising an anode, a cathode, and a light-emitting layer. The electroluminescent element is further characterized in that: the light-emitting layer contains a first compound and a sec...  
WO/2014/051521A1
The present invention relates to methods and compositions for detecting an interaction between a protein and a ligand, comprising: (i) binding at least one fluorescent molecular rotor to said ligand or protein; and (ii) detecting a chang...  
WO/2014/041125A1
The present invention relates to novel inhibitors of p21. These inhibitors are useful as therapeutic agents for promoting cell regeneration and in the treatment of cancer. Improvement of cell regeneration is particularly desirable in pat...  
WO/2014/015935A3
The present invention concerns particular fluorenes, the use of the compound in an electronic device, and an electronic device containing at least one of these compounds. The present invention further concerns a method for producing the ...  
WO/2014/015935A2
The present invention concerns particular fluorenes, the use of the compound in an electronic device, and an electronic device containing at least one of these compounds. The present invention further concerns a method for producing the ...  
WO/2014/017045A1
Provided are the following: an organic compound that, as a material for an organic electroluminescent element having high efficiency and high durability, has excellent positive hole injection/transport performance, has electron stopping ...  
WO/2014/017042A1
[Problem] To manufacture, in a stable manner, an organic photoelectric conversion element having an equivalent performance, and an imaging element provided with the same. [Solution] A film-forming organic material (60) used for dry film-...  
WO/2014/011762A1
A method is provided for N-alkylation of acridine compounds by reduction of acridines to corresponding acridans to improve the reactivity of the acridine nitrogen, and subsequent N-alkylation of the acridans in ionic liquid solvents to p...  
WO/2014/011762A8
A method is provided for N-alkylation of acridine compounds by reduction of acridines to corresponding acridans to improve the reactivity of the acridine nitrogen, and subsequent N-alkylation of the acridans in ionic liquid solvents to p...  
WO/2013/182263A1
The invention relates to specific phenanthrenes, the use of the compound in an electronic device, and an electronic device containing at least one of said compounds. The invention further relates to a method for producing the compound an...  
WO/2013/153780A1
[Problem] To provide an organic compound that, as a material for a high-efficiency, high-durability organic electroluminescent element, has superior hole injection/transport performance, has electron stopping ability, and has the charact...  
WO/2013/102249A1
The present invention provided N-phenylpiperazine derivatives for use as multiple binders and/or antagonists of α1A adrenoceptors, α1D adrenoceptors and 5-HT1A serotonin receptors. These substances are candidates to prototypes for the ...  
WO/2013/093019A1
The present invention relates to a compound of general formula (I) in which: - R1 and R2 are simultaneously or independently H, OH, OCH3 or a C1-C5 alkyl radical, - R3 and R4 are simultaneously CH3, - or R3 is H and R4 is CH3, CH2CH3 or ...  
WO/2013/091052A1
The present invention relates to oncology, in particular to a molecular compound denominated here as "oncoloose", which is capable of selectively destroying solid tumour cells without affecting rapidly replicating healthy cells. The pres...  
WO/2013/089460A1
The present invention relates to a novel chemical compound having an acridine structure, and to an organic light-emitting diode using same, and more particularly, to a novel chemical compound having an acridine structure, and to an organ...  
WO/2013/044123A1
The present invention provides for methods for therapeutic use of dimeric compound B3C and related compounds to treat Parkinson's disease (PD) and Parkinsonism. B3C is neuroprotective and has utility as a therapeutic agent for the treatm...  
WO/2013/033430A1
Acridine containing cispiaiin compounds have been disclosed that show greater efficacy against cancer than other cisplatin compounds. Methods of delivery of those more effective eisp!aiin compounds to the nucleus in cancer ceils is discl...  
WO/2013/026866A3
The present invention relates to methods of controlling or preventing phytopathogenic diseases on useful plants or on propagation material thereof comprising applying to useful plants, the locus thereof or propagation material thereof a ...  
WO/2013/022494A3
Sensors and methods for determination of analytes are provided. Analytes including explosives (e.g., RDX or PETN) may be determined by monitoring, for example, a change in an optical signal of a material upon exposure to the analyte. In ...  
WO/2013/011954A1
An organic electroluminescence element using a compound represented by general formula (1) in a light-emitting layer exhibits a high emission efficiency and is inexpensive to manufacture. (1) At least one of R1 through R8 and R17 represe...  
WO/2012/147330A1
[Problem] To provide an organic compound, as a material for a highly efficient and highly durable organic electroluminescent element, which exhibits excellent hole injection and transportation capabilities and has electron stopping abili...  
WO/2012/141249A1
An organic electroluminescent element using a compound represented by general formula (AA) has high luminous efficiency and excellent color purity, while being suppressed in chromaticity change due to driving deterioration. (In the formu...  
WO/2012/137741A1
A method for purifying an organic material, which can sublimate and purify an organic material having a high sublimation temperature and high heat resistance within a short time with high purity and high yield. The method comprises: redu...  
WO/2012/128898A1
Provided are compounds comprising two DNA supramolecular binding molecules covalently joined by a linker group. Also provided are multisignal labeling reagents comprising (i) an oligomer of nucleotides or nucleotide analogs; (ii) a DNA s...  
WO/2012/049828A1
An aromatic heterocyclic derivative represented by formula (1); a material for an organic electroluminescent element; and an organic electroluminescent element comprising the derivative or the material.  
WO/2012/036573A2
The present invention relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The invention provides compositions, pharmace...  
WO/2012/036573A3
The present invention relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The invention provides compositions, pharmace...  
WO/2012/031534A1
Disclosed are 1,2,3,4,5,6,7,8-octohydro-9-phenylacetamidoacridine and salts thereof, as well as a preparation method and pharmaceutical use thereof. The compound can be used in the preparation of a medicament for treating cardiovascular ...  
WO/2012/033061A1
Provided is an organic electroluminescent element having superior luminous efficiency and durability as well as a low drive voltage and superior heat resistance. The organic electroluminescent element has a pair of electrodes formed on a...  
WO/2012/032990A1
To provide a compound which contributes to providing a photoelectric conversion element that exhibits high photoelectric conversion efficiency, low dark current, and rapid response, and which does not decompose during vapor deposition. T...  
WO/2012/028167A3
Acridinium esters show strong chemiluminescence under reducing conditions. Reducing conditions involve reduced metal ions or reduced aromatic quinones. This chemistry can be used in the detection and quantification of acridinium ester, (...  
WO/2012/029253A1
Nitrogen-containing aromatic heterocyclic derivative represented by the formula. X1 to X3 represent a single bond, CRaRb, NRc, an oxygen atom, or a sulfur atom. In the case where all of X1 to X3 have a single bond, at least one of Ara, A...  
WO/2012/024670A3
The disclosure provides methods of treating glioblastoma, methods of screening for compounds that treat glioblastoma, and pharmaceutical compositions useful the treatment of glioblastoma.  
WO/2012/024670A2
The disclosure provides methods of treating glioblastoma, methods of screening for compounds that treat glioblastoma, and pharmaceutical compositions useful in the treatment of glioblastoma.  
WO/2011/156889A1
There is provided modulators of Nrf2 protein which comprises a compound which binds at least one of the BTB domain, IVR domain and Kelch domain of Keap1 protein, activating or inhibiting Nrf2. There is also provided pharmaceutical compos...  
WO/2011/155169A1
Provided are organic compounds that, as materials for high efficiency, high durability organic electroluminescence elements, have excellent positive hole-injection and/or -transport capabilities, are able to block electrons, are very sta...  
WO/2011/123911A1
The present invention can be used as an antitumoral medicament for testosterone-dependent tumours, in particular prostate cancer. The invention is a molecular compound formed by testosterone molecules chemically linked to molecules of a ...  
WO/2011/127406A2
The present disclosure is directed to compounds of Formula I: which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Ha...  
WO/2011/127406A3
The present disclosure is directed to compounds of Formula I: which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Ha...  
WO/2011/105700A1
Provided are novel organic electroluminescent compounds, and organic electroluminescent devices comprising the same. Since the organic electroluminescent compounds exhibit high luminous efficiency in blue color, and excellent life proper...  
WO/2011/099606A1
A photoelectric element includes a conductive layer, an organic photoelectric layer, a blocking layer and a transparent conductive layer, the organic photoelectric layer contains a p type organic photoelectric material having a glass tra...  
WO/2011/093603A1
Provided are a novel organic electroluminescent compound and an organic electroluminescent device using the same. Since the organic electroluminescent compound exhibits good luminous efficiency and excellent life property, it may be used...  
WO/2011/086178A1
The present invention concerns the discovery of new selective inhibitors of ubiquitin specific proteases, their process of preparation and their therapeutic use.  
WO/2011/070177A3
Disclosed are compounds and methods for treating neurological and other disorders by administering to a subject in need thereof an effective amount of a compound having binding and/or modulation specificity for GFRα receptor molecules, ...  

Matches 1 - 50 out of 1,110